AU2001274171A1 - Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof - Google Patents

Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof

Info

Publication number
AU2001274171A1
AU2001274171A1 AU2001274171A AU7417101A AU2001274171A1 AU 2001274171 A1 AU2001274171 A1 AU 2001274171A1 AU 2001274171 A AU2001274171 A AU 2001274171A AU 7417101 A AU7417101 A AU 7417101A AU 2001274171 A1 AU2001274171 A1 AU 2001274171A1
Authority
AU
Australia
Prior art keywords
pharmaceutical
compositions containing
cosmetic compositions
containing same
aminothiolester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274171A
Inventor
Guy Fournet
Jacques Gore
Gerard Antony Quash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of AU2001274171A1 publication Critical patent/AU2001274171A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/22—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
AU2001274171A 2000-05-31 2001-05-31 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof Abandoned AU2001274171A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0007029A FR2809727B1 (en) 2000-05-31 2000-05-31 NOVEL AMINOTHIOLESTER COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND USES THEREOF
FR0007029 2000-05-31
PCT/FR2001/001694 WO2001092220A1 (en) 2000-05-31 2001-05-31 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof

Publications (1)

Publication Number Publication Date
AU2001274171A1 true AU2001274171A1 (en) 2001-12-11

Family

ID=8850863

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274171A Abandoned AU2001274171A1 (en) 2000-05-31 2001-05-31 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof

Country Status (10)

Country Link
US (1) US8026231B2 (en)
EP (1) EP1296946B1 (en)
JP (1) JP4855626B2 (en)
AR (1) AR028122A1 (en)
AT (1) ATE264839T1 (en)
AU (1) AU2001274171A1 (en)
DE (1) DE60102925T2 (en)
ES (1) ES2219530T3 (en)
FR (1) FR2809727B1 (en)
WO (1) WO2001092220A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2983492B1 (en) * 2011-12-06 2015-10-30 Advanced Biodesign EX VIVO TUMOR PURGE METHOD OF A BIOLOGICAL SAMPLE
JP7062593B2 (en) 2015-10-15 2022-05-06 アドヴァンスト・バイオデザイン Aminothiol ester compounds, or pharmaceutically acceptable salts thereof, for use in the treatment of cancer
CA3001201C (en) * 2015-10-15 2023-07-11 Advanced Biodesign Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the h2o2 level in cancer cells of a subject
FR3047734B1 (en) * 2016-02-17 2019-09-06 Advanced Biodesign PROCESS FOR THE PREPARATION OF AMINOTHIOLESTER COMPOUNDS AND THEIR SALTS
LT3833657T (en) 2019-07-31 2022-10-10 Advanced Biodesign Aminothiolester compounds and uses thereof
EP4035666A1 (en) 2021-01-29 2022-08-03 Advanced Biodesign Aminothiolester compound or derivative thereof for use as an immunomodulatory agent
FR3119314A1 (en) 2021-01-29 2022-08-05 Advanced Biodesign Lipid nanocapsule comprising at least one aminothiolester compound or one of its pharmaceutically acceptable derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051528A (en) 1990-04-24 1991-09-24 Eastman Kodak Company Recovery process for ethylene glycol and dimethylterephthalate
JPH0797350A (en) * 1993-08-02 1995-04-11 Mitsubishi Chem Corp Benzoylacetylene derivative
FR2761606B1 (en) * 1997-04-08 1999-05-14 Cird Galderma USE OF AMINOTHIOLESTER DERIVATIVES IN THE PHARMACEUTICAL FIELD
PT973715E (en) 1997-12-02 2002-12-31 Heinrich Smuda PROCESS FOR THE RECOVERY OF TEREFTALIC ACID AND ETHYLENOGLYLOL FROM WASTES OF POLYETHYLENE TEREFTALATE
FR2777001B1 (en) * 1998-04-01 2000-06-09 Cird Galderma 6,8-DIMERCAPTOOCTANOIC ACID DERIVATIVES SUBSTITUTED IN 6-S AND / OR 8-S BY RADICAL (3-METHYLTHIOPROPANOYL) AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER TUMORS
DE60042656D1 (en) 1999-10-22 2009-09-10 Teijin Ltd METHOD FOR THE SEPARATION AND RECOVERY OF DIMETHYLTEREPHTHALATE AND ETHYLENE GLYCOL FROM POLYESTER WASTE
JP3808672B2 (en) 1999-11-26 2006-08-16 東洋製罐株式会社 Industrial recovery method of terephthalic acid from recovered pulverized polyethylene terephthalate

Also Published As

Publication number Publication date
ATE264839T1 (en) 2004-05-15
EP1296946B1 (en) 2004-04-21
DE60102925D1 (en) 2004-05-27
WO2001092220A1 (en) 2001-12-06
JP4855626B2 (en) 2012-01-18
JP2003535076A (en) 2003-11-25
ES2219530T3 (en) 2004-12-01
EP1296946A1 (en) 2003-04-02
US8026231B2 (en) 2011-09-27
FR2809727A1 (en) 2001-12-07
AR028122A1 (en) 2003-04-23
US20070032476A1 (en) 2007-02-08
DE60102925T2 (en) 2005-04-07
FR2809727B1 (en) 2002-07-26

Similar Documents

Publication Publication Date Title
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
DZ3313A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2001282877A1 (en) Cosmetic compositions
DZ3311A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001259604A1 (en) Novel quaternary compounds, compositions containing them, and uses thereof
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
AU7645701A (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
AU2001274307A1 (en) Pharmaceutical compositions
AU2001265919A1 (en) Cosmetic compositions
HUP0400967A3 (en) Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them
AU2001293728A1 (en) Cosmetic composition
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
ZA997511B (en) Novel heteroethynlene compounds and pharmaceutical and cosmetic compositions containing same.
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2001274171A1 (en) Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
AU4085201A (en) Pharmaceutical composition
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
AU2000274826A1 (en) Cosmetic compositions